Technical Analysis for FLDM - Fluidigm Corporation

Grade Last Price % Change Price Change
grade A 13.81 1.17% 0.16
FLDM closed up 1.17 percent on Monday, March 18, 2019, on 1.78 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical FLDM trend table...

Date Alert Name Type % Chg
Mar 18 Pocket Pivot Bullish Swing Setup 0.00%
Mar 18 Calm After Storm Range Contraction 0.00%
Mar 18 Upper Bollinger Band Walk Strength 0.00%
Mar 18 Inside Day Range Contraction 0.00%
Mar 18 Wide Bands Range Expansion 0.00%
Mar 18 Above Upper BB Strength 0.00%
Mar 18 Overbought Stochastic Strength 0.00%
Mar 18 Upper Bollinger Band Touch Strength 0.00%
Mar 15 Calm After Storm Range Contraction 1.17%
Mar 15 Upper Bollinger Band Walk Strength 1.17%

Older signals for FLDM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Fluidigm Corporation develops, manufactures, and markets microfluidic systems for academic research institutions, clinical laboratories, pharmaceutical companies, and biotechnology and Ag-Bio companies. Its proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits (IFCs), assays, and other reagents. The company's products include BioMark HD system that performs high-throughput gene expression analysis, single-cell gene expression analysis, single nucleotide polymorphism (SNP) genotyping, and digital polymerase chain reaction (PCR) using Fluidigm DELTAgene and SNPtype assays, other chemistries, and Fluidigm dynamic array and digital array IFCs; and EP1 system that performs SNP genotyping using Fluidigm SNPtype assays or TagMan assays, as well as end-point digital PCR using TaqMan assays, and Fluidigm Dynamic Array and Digital Array IFCs. Its products also comprise C1 Single-Cell Auto Prep system, which enables rapid and reliable isolation, processing, and profiling of individual cells for genomic analysis for various applications, such as targeted single-cell gene expression and single-cell messenger ribonucleic acids analysis; and Access Array system that enables automated sample preparation, barcoding, and tagging of targeted resequencing libraries. In addition, the company offers dynamic array, digital array, C1 single-cell auto prep array, and access array IFCs; and DELTAgene and SNPtype assays, and access array target-specific primers. Fluidigm Corporation distributes its systems through direct sales force and support organizations in North America, Europe, and the Asia-Pacific; and through distributors or sales agents in Europe, Latin America, the Middle East, and the Asia-Pacific countries. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
Biotechnology Pharmaceutical Biology Natural Sciences Molecular Biology Gene Expression Laboratory Techniques Genotyping Polymerase Chain Reaction SNP
Is FLDM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 14.5
52 Week Low 4.65
Average Volume 990,244
200-Day Moving Average 7.8841
50-Day Moving Average 10.0436
20-Day Moving Average 11.669
10-Day Moving Average 12.312
Average True Range 0.6047
ADX 53.46
+DI 44.5425
-DI 6.1161
Chandelier Exit (Long, 3 ATRs ) 12.6859
Chandelier Exit (Short, 3 ATRs ) 11.434099999999999
Upper Bollinger Band 13.7154
Lower Bollinger Band 9.6226
Percent B (%b) 1.02
BandWidth 35.074128
MACD Line 0.9839
MACD Signal Line 0.7823
MACD Histogram 0.2016
Fundamentals Value
Market Cap 406.2 Million
Num Shares 29.4 Million
EPS -2.45
Price-to-Earnings (P/E) Ratio -5.64
Price-to-Sales 1.81
Price-to-Book 7.30
PEG Ratio 0.38
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.28
Resistance 3 (R3) 14.23 14.03 14.20
Resistance 2 (R2) 14.03 13.91 14.05 14.17
Resistance 1 (R1) 13.92 13.84 13.98 13.97 14.15
Pivot Point 13.72 13.72 13.75 13.74 13.72
Support 1 (S1) 13.61 13.60 13.67 13.66 13.47
Support 2 (S2) 13.41 13.53 13.43 13.45
Support 3 (S3) 13.30 13.41 13.42
Support 4 (S4) 13.35